Related Experiment Videos
T cell signaling and autoimmune diabetes
1Department of Medicine C, Assaf Harofe Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Israel.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|January 12, 2001
Summary
Autoimmune diabetes is linked to defective T-cell receptor (TCR) signaling. Impaired signaling in T lymphocytes may disrupt immune balance and contribute to disease development.
Area of Science:
- Immunology
- Cell Biology
- Endocrinology
Background:
- T-cell receptor (TCR) stimulation triggers intracellular signals regulating T-cell function.
- Defective TCR signaling is implicated in autoimmune diabetes, particularly in NOD mice via the PKC/p21ras/p42mapk pathway.
- Limited data exist on T-cell signaling defects in human autoimmune diabetes patients.
Purpose of the Study:
- To investigate T-cell signaling defects in autoimmune diabetes.
- To correlate these defects with aberrant T-cell activation and proliferation.
- To explore the potential role in Th1/Th2 cytokine imbalance and disease pathogenesis.
Main Methods:
- Analysis of T-cell signaling pathways, including PKC activation and the p21ras cascade.
- Assessment of T-cell proliferation and cytokine production in response to stimuli like lectins and anti-CD3 mAb.
- Comparison of signaling defects in prediabetic NOD mice and patients with autoimmune diabetes mellitus.
Main Results:
- NOD mice show reduced TCR-mediated signal transduction along the PKC/p21ras/p42mapk pathway.
- Some studies report impaired PKC activation, cytokine production, and T-cell hyporesponsiveness in patients.
- Defective expression and function of the p21ras cascade have been observed in patients with autoimmune diabetes.
Conclusions:
- Lymphocytes in autoimmune diabetes exhibit defective TCR-mediated signaling.
- This defect may lead to aberrant T-cell activation and proliferation.
- An imbalance in Th1/Th2 cytokine patterns, promoting disease, is a potential consequence.